Get the Stockscreener App
1.08
0.93%
0.01
Pre-market:
1.10
0.02
+1.85%
Actinium Pharmaceuticals Inc stock is traded at $1.08, with a volume of 40,494.
It is up +0.93% in the last 24 hours and down -5.26% over the past month.
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for patients with cancers lacking effective treatment options. Its lead product candidate is Iomab-B that is in Phase III clinical studies for myeloablation and conditioning of the bone marrow prior to a bone marrow transplant for patients with relapsed or refractory acute myeloid leukemia (AML) age 55 and older. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60, as well as in Phase I clinical trials in combination with CLAG-M for patients with relapsed or refractory AML; and Actimab-M that is in Phase I clinical trials for patients with refractory multiple myeloma. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.
See More
Previous Close:
$1.07
Open:
$1.1
24h Volume:
40,494
Relative Volume:
0.33
Market Cap:
$33.69M
Revenue:
$90,000
Net Income/Loss:
$-34.60M
P/E Ratio:
-0.9738
EPS:
-1.1091
Net Cash Flow:
$-25.04M
1W Performance:
-1.82%
1M Performance:
-5.26%
6M Performance:
-32.08%
1Y Performance:
-31.65%
1-Day Range:
$1.065
$1.12
1-Week Range:
$1.06
$1.17
52-Week Range:
$1.02
$2.41
Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile
Name
Actinium Pharmaceuticals Inc
Sector
Industry
Phone
646-767-3870
Address
275 Madison Avenue, 7th Floor, New York, NY
Compare ATNM vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATNM
Actinium Pharmaceuticals Inc
|
1.08 | 33.69M | 90,000 | -34.60M | -25.04M | -1.1091 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-24 | Downgrade | B. Riley Securities | Buy → Neutral |
| May-14-24 | Initiated | Stephens | Overweight |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Feb-21-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-08-22 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-25-22 | Initiated | B. Riley Securities | Buy |
| Nov-05-20 | Initiated | Alliance Global Partners | Buy |
| Dec-06-17 | Initiated | B. Riley FBR, Inc. | Buy |
| Oct-23-17 | Resumed | ROTH Capital | Buy |
| Sep-14-17 | Initiated | Maxim Group | Buy |
| Aug-25-16 | Initiated | ROTH Capital | Buy |
| Feb-29-16 | Initiated | H.C. Wainwright | Buy |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Oct-01-14 | Initiated | MLV & Co | Buy |
| Jul-22-14 | Initiated | Canaccord Genuity | Buy |
View All
Actinium Pharmaceuticals Inc Stock (ATNM) Latest News
Comparing UCB (OTCMKTS:UCBJF) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Fundamentals Check: Is Actinium Pharmaceuticals Inc undervalued by DCF analysis - baoquankhu1.vn
If You Invested $1,000 in Actinium Pharmac (ATNM) - Stock Titan
Stop Loss: What is the next catalyst for Actinium Pharmaceuticals IncCEO Change & Reliable Breakout Forecasts - baoquankhu1.vn
Analysis Recap: Is Actinium Pharmaceuticals Inc stock good for income investors2026 Market Mood & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Wall Street Recap: Is Actinium Pharmaceuticals Inc stock trending bullishInflation Watch & Reliable Intraday Trade Alerts - baoquankhu1.vn
IPO Launch: Can Actinium Pharmaceuticals Inc stock double in the next year2026 Short Interest & High Yield Equity Trading Tips - baoquankhu1.vn
Aug Shorts: What is the dividend yield of Actinium Pharmaceuticals Inc2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
Market Rankings: Is Actinium Pharmaceuticals Inc undervalued by DCF analysisJuly 2025 Levels & AI Forecast Swing Trade Picks - baoquankhu1.vn
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Analysis Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Retail & AI Enhanced Execution Alerts - baoquankhu1.vn
ATNM Should I Buy - Intellectia AI
Is now the right time to enter Actinium Pharmaceuticals Inc.Market Activity Recap & AI Based Buy/Sell Signal Reports - mfd.ru
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
Performance Recap: Can Actinium Pharmaceuticals Inc outperform in the next rallyJuly 2025 Volume & Verified Stock Trade Ideas - baoquankhu1.vn
ATNM PE Ratio & Valuation, Is ATNM Overvalued - Intellectia AI
Actinium Pharmaceuticals Announces CFO Resignation and New Appointment - TradingView
Actinium Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective as of February 27, 2026 - marketscreener.com
Earnings Report: What is the next catalyst for Actinium Pharmaceuticals IncShare Buyback & Safe Capital Growth Stock Tips - baoquankhu1.vn
Earnings Risk: What is the next catalyst for Actinium Pharmaceuticals Inc2025 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
Profit Recap: Is Actinium Pharmaceuticals Inc stock trending bullish2025 Trade Ideas & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
US Market Wrap: Is now the right time to enter Actinium Pharmaceuticals IncDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
Head-To-Head Contrast: Actinium Pharmaceuticals (NYSE:ATNM) versus Avenue Therapeutics (NASDAQ:ATXI) - Defense World
Rally Mode: What is the next catalyst for Actinium Pharmaceuticals IncQuarterly Earnings Report & Smart Allocation Stock Reports - baoquankhu1.vn
What’s the outlook for Actinium Pharmaceuticals Inc.’s sector2025 Market WrapUp & Risk Controlled Swing Alerts - mfd.ru
Contrasting NexImmune (OTCMKTS:NEXI) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Analyzing Leap Therapeutics (NASDAQ:LPTX) and Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Retail Trends: Should I invest in IGM Biosciences Inc before earningsDay Trade & Reliable Price Breakout Alerts - baoquankhu1.vn
Reviewing Actinium Pharmaceuticals (NYSE:ATNM) & Aadi Bioscience (NASDAQ:AADI) - Defense World
How Actinium Pharmaceuticals Inc. (7AY1) stock responds to job market shiftsMarket Sentiment Indicators & Free Stay Ahead With Picks - bollywoodhelpline.com
Aug Selloffs: Is Actinium Pharmaceuticals Inc stock trending bullishJuly 2025 Market Mood & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Actinium Stock Gains Momentum from Clinical Trial Developments - AD HOC NEWS
Short Squeeze: What is the next catalyst for Actinium Pharmaceuticals IncProfit Target & Technical Confirmation Trade Alerts - baoquankhu1.vn
Aug Outlook: Will Actinium Pharmaceuticals Inc. stock outperform value stocks2025 Trade Ideas & Safe Capital Growth Plans - Bộ Nội Vụ
Why is Actinium Pharmaceuticals stock rising today? - MSN
Actinium Pharmaceuticals (NYSE:ATNM) & ProMetic Life Sciences (OTCMKTS:PFSCF) Head to Head Comparison - Defense World
Published on: 2026-01-09 08:22:12 - Улправда
Will Actinium Pharmaceuticals Inc. (Delaware) stock outperform foreign stocksQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - ulpravda.ru
Why Actinium Pharmaceuticals Inc. stock remains on buy listsWeekly Stock Analysis & High Accuracy Trade Signal Alerts - Улправда
Can Actinium Pharmaceuticals Inc. stock hit analyst price targetsJuly 2025 Momentum & Breakout Confirmation Trade Signals - Улправда
How Actinium Pharmaceuticals Inc. (Delaware) stock valuation compares with sectorMarket Activity Report & Safe Entry Momentum Stock Tips - ulpravda.ru
Does Actinium Pharmaceuticals Inc. stock trade at a discount to peers2025 Performance Recap & Fast Moving Market Watchlists - Улправда
How geopolitical tensions affect Actinium Pharmaceuticals Inc. stockJuly 2025 Rallies & Capital Protection Trading Alerts - Улправда
Actinium Pharmaceuticals, Inc. (Delaware) Common Stock (NY: ATNM - FinancialContent
Can Actinium Pharmaceuticals Inc. stock continue upward trendWeekly Profit Summary & Detailed Earnings Play Alerts - ulpravda.ru
Can Actinium Pharmaceuticals Inc. (Delaware) stock sustain revenue momentum2026 world cup usa national team semifinals goalkeepers set piece tactics odds analysis tactical review - ulpravda.ru
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year? - Yahoo Finance
Published on: 2025-12-20 18:07:18 - Улправда
Will Actinium Pharmaceuticals Inc. stock benefit from upcoming earnings reportsForecast Cut & Short-Term High Return Ideas - Улправда
Will Actinium Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
AstraZeneca’s Long-Term Isotope Deal Validates Actinium Pharmaceuticals’ Core Technology - AD HOC NEWS
Actinium Pharmaceuticals Inc Stock (ATNM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):